Haloperidol: all 80 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency DepartmentNot yet recruitingNCT07726069Early Phase 1
• Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?RecruitingNCT07109245Phase 4
• Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency DepartmentRecruitingNCT06395428Phase 4
• The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBMNot yet recruitingNCT06218524Phase 2
• Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing StrategyRecruitingNCT05431595Phase 2/3
• Haloperidol, Droperidol, Ondansetron in Cannabis HyperemesisTerminatedNCT05065567Phase 3Results posted
• Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)CompletedNCT04327843Phase 3Results posted
• TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency SettingCompletedNCT03639558Phase 4Results posted
• Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer PatientsCompletedNCT03489551Phase 4Results posted
• Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerActive, not recruitingNCT03021486Phase 2/3Results posted
• Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency DepartmentTerminatedNCT02972502Phase 4Results posted
• Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
• Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or ThoracotomyCompletedNCT02213900Phase 4Results posted
• D1 and D2 Dopamine Receptors in Gambling and Amphetamine ReinforcementCompletedNCT02203786Phase 2Results posted
• Haloperidol vs Conventional Therapy for GastroparesisTerminatedNCT02057549Phase 4Results posted
• Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk PatientsCompletedNCT01639599Not applicableResults posted
• The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) StudyCompletedNCT01211522Phase 3Results posted
• Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy VolunteersCompletedNCT01204255Not applicableResults posted
• Customized Adherence Enhancement Plus Long-acting Injectable AntipsychoticCompletedNCT01152697Not applicableResults posted
• Pharmacological Management of DeliriumCompletedNCT00842608Not applicableResults posted
• A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency RoomCompletedNCT00457366Phase 4Results posted
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic DepressionCompletedNCT00340379Phase 2/3Results posted
• ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and DeliriumTerminatedNCT00300391Phase 3Results posted
• Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency DepartmentCompletedNCT07246187Phase 3
• Comparison of Haloperidol and Ondansetron in Reducing Postoperative Nausea and Vomiting in RA-SAB PatientsCompletedNCT07087925Not applicable
• Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONVCompletedNCT06428084Phase 2
• Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill ElderlyCompletedNCT06168773Phase 2/3
• Learning and Decision-makingCompletedNCT06014606Not applicable
• Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After LaparoscopyCompletedNCT05246631Phase 4
• HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled TrialCompletedNCT04833023Phase 3
• Haloperidol for the Treatment of Nausea and Vomiting in the EDCompletedNCT04764344Phase 4
• Comparing Haloperidol and Olanzapine in Treating Terminal DeliriumStatus unknownNCT04750395Phase 2
• Treatment Strategies in CHSCompletedNCT04176055Phase 4
• Symptomatic Therapy for Patients With Huntington's DiseaseStatus unknownNCT04071639Phase 1
• Pharmacological Modulation of Belief SalienceCompletedNCT03754062Phase 1
• Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative CareActive, not recruitingNCT03743649Phase 2/3
• Haloperidol for Delirium in Adult Critically Ill PatientsTerminatedNCT03628391Phase 3
• Agents Intervening Against Delirium in Intensive Care UnitStatus unknownNCT03392376Phase 4
• PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdelStatus unknownNCT03199950Phase 4
• Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With SchizophreniaCompletedNCT03075657Phase 4
• Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)CompletedNCT03056482Phase 4
• Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural SedationCompletedNCT02909465Phase 4
• IV Haloperidol for the Treatment of Headache in the EDCompletedNCT02747511Phase 4
• Baden Prevention and Reduction of Incidence of Postoperative Delirium TrialCompletedNCT02433041Phase 4
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Treatment of Hypoactive Delirium and Outcome MeasuresStatus unknownNCT02345902Phase 3
• Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
• Ketamine Versus Haloperidol for Severe Agitation Outside the HospitalWithdrawnNCT02103881Phase 4
• Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCTWithdrawnNCT02098499Phase 4
• Brain Networks and Addiction SusceptibilityCompletedNCT01924468Phase 1
• Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for DeliriumCompletedNCT01862302Phase 3
• Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of DeliriumCompletedNCT01811459Phase 3
• pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for DeliriumCompletedNCT01785290Phase 4
• Haloperidol vs. Valproate in AgitationCompletedNCT01750541Phase 3
• Evidence of Haloperidol Absorption After Topical AdministrationWithdrawnNCT01684969Early Phase 1
• Haloperidol Prophylaxis in Older Emergency Department PatientsCompletedNCT01530308Phase 4
• Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated PatientCompletedNCT01501123Not applicable
• Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy EvaluationCompletedNCT01485692Not applicable
• Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy VolunteersStatus unknownNCT01259973Phase 1
• Preventing ICU Subsyndromal Delirium Conversion to Delirium With HaloperidolCompletedNCT01174290Phase 4
• Effects of Aripiprazole and Haloperidol on Mesolimbic System FunctioningCompletedNCT01161277Phase 4
• Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
• Lamictal TM, Haloperidol Decanoate in SchizophreniaTerminatedNCT00947375Phase 4
• To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal VolunteersCompletedNCT00946491Phase 1
• Haloperidol vs Olanzapine for the Management of ICU DeliriumTerminatedNCT00833300Not applicable
• Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)CompletedNCT00753051Not applicable
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy HumansCompletedNCT00625170Not applicable
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy HumansCompletedNCT00625014Not applicable
• Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care PatientsTerminatedNCT00599287Phase 3
• Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaCompletedNCT00485901Phase 3
• Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDCompletedNCT00433121Phase 4
• Pilot Study of Haloperidol to Treat Critical Illness DeliriumCompletedNCT00429676Phase 2
• A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00253110Phase 4
• Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip SurgeryCompletedNCT00250237Phase 3
• Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCompletedNCT00191555Phase 4
• One Year Drug Treatment in First-Episode SchizophreniaCompletedNCT00159081Phase 4
• Optimization of Acute Treatment in First Episode SchizophreniaStatus unknownNCT00157378Phase 4
• The MIND Study: Modifying the INcidence of DeliriumCompletedNCT00096863Phase 2
• Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
• Treatment of Behavioral Symptoms in Alzheimer's DiseaseCompletedNCT00009217Phase 4

← Haloperidol overview